# Francisco Sánchez-Vega

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francisco-sanchez-vega/

## Facts

| Field | Value |
| --- | --- |
| Citations | 71,928 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 85 |
| i10-index | 142 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5025867816 |
| ORCID iD | https://orcid.org/0000-0002-2990-4893 |
| Works | 433 |

## Researcher papers

Showing 12 of 17.

- [An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics](https://scholariq.org/papers/an-integrated-tcga-pan-cancer-clinical-data-resource-to-drive-high-quality/)
- [Oncogenic Signaling Pathways in The Cancer Genome Atlas](https://scholariq.org/papers/oncogenic-signaling-pathways-in-the-cancer-genome-atlas/)
- [Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer](https://scholariq.org/papers/cell-of-origin-patterns-dominate-the-molecular-classification-of-10-000-tumors/)
- [Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation](https://scholariq.org/papers/machine-learning-identifies-stemness-features-associated-with-oncogenic/)
- [Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing](https://scholariq.org/papers/molecular-determinants-of-response-to-anti-programmed-cell-death-pd-1-and-anti/)
- [Genomic and Functional Approaches to Understanding Cancer Aneuploidy](https://scholariq.org/papers/genomic-and-functional-approaches-to-understanding-cancer-aneuploidy/)
- [Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer](https://scholariq.org/papers/genomic-features-of-response-to-combination-immunotherapy-in-patients-with/)
- [Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients](https://scholariq.org/papers/comprehensive-analysis-of-alternative-splicing-across-tumors-from-8-705-patients/)
- [Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines](https://scholariq.org/papers/scalable-open-science-approach-for-mutation-calling-of-tumor-exomes-using/)
- [Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients](https://scholariq.org/papers/genomic-characterization-of-metastatic-patterns-from-prospective-clinical/)
- [Driver Fusions and Their Implications in the Development and Treatment of Human Cancers](https://scholariq.org/papers/driver-fusions-and-their-implications-in-the-development-and-treatment-of-human/)
- [Integrative Molecular Characterization of Malignant Pleural Mesothelioma](https://scholariq.org/papers/integrative-molecular-characterization-of-malignant-pleural-mesothelioma/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.